Gag polyprotein

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 21: Line 21:
</StructureSection>
</StructureSection>
-
==3D structures of Gag polyprotein==
 
-
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
 
-
{{#tree:id=OrganizedByTopic|openlevels=0|
 
- 
-
*Gag polyprotein from HIV-1
 
- 
-
**[[2h3i]] – Gag residues 2-132 – HIV-1<BR />
 
-
**[[2h3f]], [[2h3i]], [[1uph]] - Gag residues 2-132 – NMR<BR />
 
-
**[[5mdg]], [[5mdf]], [[5mde]], [[5mdd]], [[5mdc]], [[5mdb]], [[5mda]], [[5md9]], [[5md8]], [[5md7]], [[5md6]], [[5md5]], [[5md4]], [[5md3]], [[5md2]], [[5md1]], [[5md0]], [[5mcz]] - Gag residues 1-221 – Cryo EM<br />
 
-
**[[1l6n]] - Gag residues 1-283 – NMR<BR />
 
-
**[[1gwp]] - Gag residues 132-283 – NMR<BR />
 
-
**[[2jmg]], [[2nv3]] - Gag residues 2-132 (mutant) – NMR<BR />
 
-
**[[1u57]] - Gag residues 1-48 – NMR<BR />
 
-
**[[1esk]] - Gag residues 12-53 – NMR<BR />
 
-
**[[1baj]] – Gag C terminal<BR />
 
-
**[[2znf]] – Gag zinc fingerlike domain - NMR<BR />
 
-
**[[5teo]] - Gag residues 278-377 <br />
 
-
**[[6n3j]] - Gag residues 278-377 (mutant) <br />
 
-
**[[2h3q]], [[2h3v]], [[2h3z]] - Gag residues 2-132 + phosphatidyl inositol bisphosphate - NMR<BR />
 
-
**[[1mt7]], [[1mt8]] – Gag MA-CA cleavage site + protease retropepsin (mutant) <BR />
 
-
**[[1agb]], [[1agc]], [[1agd]], [[1age]], [[1agf]] – Gag peptide + β-2 microglobulin + B*0801<BR />
 
-
**[[3p9g]], [[3p9h]], [[3obu]], [[3obx]], [[1m4p]], [[1m4q]] - Gag peptide + tumor susceptibility gene 101 protein N terminal<BR />
 
-
**[[1fgl]] – Gag residues 81-105 + cyclophilin A<BR />
 
-
**[[2xde]] - Gag residues 1-146 + inhibitor<BR />
 
-
**[[4j91]], [[4j92]], [[4j93]] - Gag residues 133-278 + inhibitor<br />
 
-
**[[6n3u]] - Gag residues 278-377 (mutant) + inhibitor<br />
 
-
**[[2x2d]] - Gag residues 133-278 + peptidyl-prolyl cis-trans isomerase A<BR />
 
-
**[[2lf4]] - Gag residues 133-363 (mutant)<br />
 
-
**[[4u0d]] - Gag residues 133-363 + Nup153 peptide<br />
 
-
**[[5upw]], [[5mcy]], [[5mcx]] - Gag residues 139-351 – Cryo EM<br />
 
-
**[[6ern]] - Gag residues 139-351 + ATP<br />
 
-
**[[6erm]] - Gag residues 139-351 + TTP derivative<br />
 
-
**[[6h09]], [[6es8]] - Gag residues 133-315 + inositol hexakisphosphate<br />
 
-
**[[2xt1]] – Gag C terminal + camelid VHH<br />
 
-
**[[1sje]], [[1sjh]] – Gag peptide + HLA-DR1<BR />
 
-
**[[1kj4]], [[1kj7]], [[1kjf]], [[1kjg]] - Gag peptide + POL polyprotein
 
- 
-
*Gag polyprotein from HIV-2
 
- 
-
**[[2wlv]] - Gag residues 99-242 – HIV-2<BR />
 
-
**[[2ec7]] – Gag – NMR<BR />
 
- 
-
*Gag polyprotein from Rous sarcoma virus
 
- 
-
**[[3g0v]], [[3g1g]], [[3g21]], [[3g1i]] - Gag C terminal – Rous sarcoma virus<BR />
 
-
**[[3g26]], [[3g28]], [[3g29]] - Gag C terminal (mutant) <BR />
 
-
**[[1p7n]] – Gag N terminal<BR />
 
-
**[[1em9]] - Gag N terminal – NMR<BR />
 
-
**[[1eoq]] - Gag C terminal – NMR<BR />
 
-
**[[1a6s]] – Gag M domain (mutant) - NMR<BR />
 
-
**[[5a9e]] - Gag residues 84-577 – Cryo EM<br />
 
- 
-
*Gag polyprotein from Simian immunodeficiency virus
 
- 
-
**[[1ecw]], [[1ed1]] - Gag<BR />
 
-
**[[2xs1]] - Gag peptide + programmed cell death 6-interacting protein
 
- 
-
*Gag polyprotein from Moloney murine leukemia virus
 
- 
-
**[[1u7k]], [[3bp9]] - Gag residues 215-345<BR />
 
-
**[[1u6p]] – Gag residues 479-534 + DNA <br />
 
-
**[[6mig]] - Gag residues 683-937 + DNA<br />
 
- 
-
*Gag polyprotein from equine infectious anemia virus
 
- 
-
**[[1hek]] – Gag
 
- 
-
*Gag polyprotein from Mason-Pfizer monkey virus
 
- 
-
**[[1cl4]] - Gag residues 49-80 (mutant) – NMR<BR />
 
- 
-
*Gag polyprotein from human spumaretrovirus
 
- 
-
**[[4jnh]] - Gag N terminal <br />
 
-
**[[4jmr]] - Gag N terminal + Env protein<br />
 
-
**[[5m1h]], [[5m1g]] - Gag residues 300-477 - NMR<br />
 
-
}}
 
==Additional Resources==
==Additional Resources==
For additional information, see: [[Human Immunodeficiency Virus]]
For additional information, see: [[Human Immunodeficiency Virus]]

Revision as of 09:09, 8 July 2019

Gag polyprotein N-terminal capsid domain of HIV-2 (PDB entry 2wlv)

Drag the structure with the mouse to rotate

Contents

Additional Resources

For additional information, see: Human Immunodeficiency Virus

Reference

  1. Coffin, J., S. Hughes, and H. Varmus, Retroviruses. 1997: Cold Spring Harbor Laboratory Press.
  2. Cite error: Invalid <ref> tag; no text was provided for refs named source
  3. 3.0 3.1 Gitti RK, Lee BM, Walker J, Summers MF, Yoo S, Sundquist WI. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 1996 Jul 12;273(5272):231-5. PMID:8662505
  4. 4.0 4.1 von Schwedler UK, Stemmler TL, Klishko VY, Li S, Albertine KH, Davis DR, Sundquist WI. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 1998 Mar 16;17(6):1555-68. PMID:9501077 doi:10.1093/emboj/17.6.1555
  5. Braaten D, Franke EK, Luban J. Cyclophilin A is required for an early step in the life cycle of human immunodeficiency virus type 1 before the initiation of reverse transcription. J Virol. 1996 Jun;70(6):3551-60. PMID:8648689
  6. Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh CT, Sodroski J, Gottlinger HG. Functional association of cyclophilin A with HIV-1 virions. Nature. 1994 Nov 24;372(6504):363-5. PMID:7969495 doi:http://dx.doi.org/10.1038/372363a0
  7. Ackerson B, Rey O, Canon J, Krogstad P. Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A. J Virol. 1998 Jan;72(1):303-8. PMID:9420228

Team from University of Missouri, Columbia, MO

Students: Zheng Wang, Allison Tegge, Xin Deng
Advisors: Jianlin Cheng, PhD, Department of Computer Science, Informatics Institute, the Life Science Center, Interdisciplinary Plant Group, University of Missouri, Columbia
Mentor: Chun Tang, PhD, Department of Biochemistry, University of Missouri, Columbia

NMR Equipment and the Authors

Created by Allison Tegge and David Canner

Proteopedia Page Contributors and Editors (what is this?)

Michal Harel, Alexander Berchansky, Joel L. Sussman

Personal tools